Traws Pharma, Inc. (TRAW) Return on equity 2015–2022
Traws Pharma, Inc. (TRAW) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-177.5%FY2022 · since FY2015: -457.7% → -177.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | -177.5% | -110.6 pp |
| FY2021 | -67.0% | -31.9 pp |
| FY2020 | -35.0% | +372.4 pp |
| FY2019 | -407.4% | -221.6 pp |
| FY2018 | -185.8% | +196.1 pp |
| FY2017 | -381.9% | — |
| FY2015 | -457.7% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice